Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • My alerts

Search

  • Advanced search
eNeuro
  • My alerts
eNeuro

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
PreviousNext
Research ArticleNew Research, Cognition and Behavior

The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex

Sébastien Tremblay, Florian Pieper, Adam Sachs, Ridha Joober and Julio Martinez-Trujillo
eNeuro 25 February 2019, 6 (1) ENEURO.0371-18.2018; DOI: https://doi.org/10.1523/ENEURO.0371-18.2018
Sébastien Tremblay
Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sébastien Tremblay
Florian Pieper
Institute for Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf 20251, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Sachs
Department of Surgery, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, K1H 8L6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ridha Joober
Douglas Mental Health University Institute, McGill University, Montreal, Québec, H4H 1R3, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ridha Joober
Julio Martinez-Trujillo
Robarts Research Institute, Departments of Psychiatry, Physiology and Pharmacology Schulich School of Medicine and Dentistry, Brain and Mind Institute, University of Western Ontario, London, Ontario, N6A 5C1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Behavioral task and performance. A, Behavioral task with the three randomly interleaved trial types. Blue dashed circles represent the focus of covert attention. Pink dashed circles indicate orientation change(s). Pink arrows indicate saccadic eye movements. Blue dot represents gaze position. B, Average behavioral performance of each subject under placebo sessions only. The colors indicate the proportion of each trial outcome in a behavioral session. Fixation break represents errors where the subject would respond before a Go signal was given. Sac. to distractor represents errors where the subject would respond to a distracting stimulus. No response represents trials where the subject would not provide a response. C, D, Line plots representing the change in overall hit rate relative to matched placebo sessions in the attention task following various doses of MPH. Hit rate is considered a proportion (Hit/Hit+Errors). Differences in proportion (hit rate) across treatment conditions are computed with χ2 tests. Asterisks represent statistically significant changes in hit rate relative to placebo sessions (χ2 test, p < 0.05). E, F, Same format as C, D but representing the proportion of specific error types across treatment conditions. Up means more errors. Refer to Materials and Methods for definitions. Error bars represent the SE of the sample proportion estimate.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Neurophysiological recordings. A, Location of chronically implanted multielectrode Utah array within the left caudal LPFC. The shaded pink area roughly represents area 8A in the macaque brain. The blue square represents implant location. P: principal sulcus. AS: arcuate sulcus superior. AI: arcuate sulcus inferior. B, Implant location based on intra-operative photography for both monkey “F” and monkey “JL” in reference to major sulci. Each small square represents one of the 96 microelectrodes on the array. Colors represent the spatial attentional tuning of the neurons recorded at each electrode site as a function of the four quadrant locations (inset). Note tuned stands for neurons that do not show attentional modulation. Inactive represents reference electrodes and grounds.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Qualitative effects of MPH on the average single neuron response. A, Attentional modulation of single neuron activity averaged over the entire sample of tuned cells and trials (sample size reported with N in figure). The trial-averaged SDFs are displayed separately for MPH and placebo (PLB) sessions. The light blue and red SDFs depict the average single neuron response on trials where attention is allocated inside, or opposite to the neuron’s preferred location (i.e., RF), respectively. The abscissa represents the time from trial onset and the ordinate the population neuronal firing rate (z-scored). Shaded areas represent SEM. The average responses during all MPH sessions are overlaid on top of the average response during placebo sessions to illustrate the near-perfect overlap in single neuron responses across treatment conditions. B, Same as in A but for monkey “JL.” C, D, Same as A, B but only including the MPH sessions showing the best behavioral improvement due to treatment (best-dose analysis; 0.86 mg/kg for monkey “F,” 0.67 mg/kg for monkey “JL”). The same absence of difference in this best-dose analysis is demonstrated by the overlap of the MPH and PLB curves in C, D.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effects of MPH on 19 single neuron response metrics. A, Visual response metrics for visually-selective neurons as a function of drug dose. Refer to Materials and Methods for the meaning of each metric. The x-axis depicts MPH drug dose using arbitrary units (a.u.), from the smallest dose to the biggest for each monkey. These are 0.43, 0.86, 1.08, 1.29, or 1.72 mg/kg for monkey “F,” and 0.33, 0.67, 0.83, 1.00, or 1.33 mg/kg for monkey “JL.” The y-axis is relative to the particular metric being plotted. Blue and green lines are for monkey “F” and monkey “JL,” respectively. The top-leftmost subplot includes the size of single neurons samples included for the computation of all the visual metrics. The red error bars correspond to the best-dose of MPH according to behavioral performance. The colored numbers to the right of each line represent the p values for the ANOVA test ran for each metric, uncorrected (top), and corrected for multiple comparisons (bottom). B, Same as in A but for the attentional response metrics of attention-selective neurons. C, Same as in A but for the saccadic response metrics of saccade-selective neurons. All error bars represent SEM.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Effects of MPH on noise correlations. Each line illustrates the median noise correlation coefficient separately for positive and negative noise correlations (blue and red, respectively) as a function of drug dose (x-axis). The x-axis uses arbitrary units, from the smallest dose of MPH to the biggest for each monkey. These are 0.43, 0.86, 1.08, 1.29, or 1.72 mg/kg for monkey “F,” and 0.33, 0.67, 0.83, 1.00, or 1.33 mg/kg for monkey “JL.” The left column presents results from analyses including all recorded neurons, independent of their selectivity. The right column includes only neurons that were selective (i.e., tuned) for the corresponding epoch. Since no tuning can be measured during the baseline fixation epoch, visual tuning was used as a replacement in this analysis. Each column presents results for each monkey independently.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Effects of MPH on noise correlation structure. A, Relationship between the signal correlation (i.e., tuning similarity) and noise correlation between every possible pairs of simultaneously recorded neurons, presented for each drug dose (colored lines). As expected, the more similar is the tuning between two neurons, the more noise they share through common inputs. B, Same as in A, although for monkey “JL.” Best dose of MPH based on behavioral performance is in bold in the legend. Error bars represent SEM.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Effects of MPH on neuronal ensemble decoding of task-related information. A, Decoding accuracy of a SVM algorithm extracting single-trial information about the visual, attentional, and saccadic representations in the neuronal ensemble activity of simultaneously recorded neurons. Decoding accuracy, used as a proxy for neuronal coding accuracy, is presented as a function of drug dose (x-axis), as in preceding figures. The purple line represents the achieved chance performance using permutation testing and overlaps roughly with the theoretical chance performance of 25%. B, Same as A but for monkey “JL.” Error bars represent SEM.

Back to top

In this issue

eneuro: 6 (1)
eNeuro
Vol. 6, Issue 1
January/February 2019
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex
Sébastien Tremblay, Florian Pieper, Adam Sachs, Ridha Joober, Julio Martinez-Trujillo
eNeuro 25 February 2019, 6 (1) ENEURO.0371-18.2018; DOI: 10.1523/ENEURO.0371-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
The Effects of Methylphenidate (Ritalin) on the Neurophysiology of the Monkey Caudal Prefrontal Cortex
Sébastien Tremblay, Florian Pieper, Adam Sachs, Ridha Joober, Julio Martinez-Trujillo
eNeuro 25 February 2019, 6 (1) ENEURO.0371-18.2018; DOI: 10.1523/ENEURO.0371-18.2018
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • attention
  • methylphenidate
  • multielectrode array
  • prefrontal cortex
  • primates
  • Ritalin

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • Visual modulation of resting state alpha oscillations
  • Optimized but Not Maximized Cue Integration for 3D Visual Perception
  • Probing proteostatic stress in degenerating photoreceptors using two complementary in vivo reporters of proteasomal activity
Show more New Research

Cognition and Behavior

  • Visual modulation of resting state alpha oscillations
  • Optimized but Not Maximized Cue Integration for 3D Visual Perception
  • Probing proteostatic stress in degenerating photoreceptors using two complementary in vivo reporters of proteasomal activity
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Blog
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Articles

  • Early Release
  • Latest Articles
  • Issue Archive
  • Video Archive
  • Editorials

For Authors

  • Information for Authors
  • Contact Information

About

  • Overview
  • Editorial Board
  • Advertise
  • For the Media
  • Privacy Policy
  • Contact Us
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2019 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.